BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 15452868)

  • 1. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).
    Wenning GK; Tison F; Seppi K; Sampaio C; Diem A; Yekhlef F; Ghorayeb I; Ory F; Galitzky M; Scaravilli T; Bozi M; Colosimo C; Gilman S; Shults CW; Quinn NP; Rascol O; Poewe W;
    Mov Disord; 2004 Dec; 19(12):1391-402. PubMed ID: 15452868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).
    Geser F; Wenning GK; Seppi K; Stampfer-Kountchev M; Scherfler C; Sawires M; Frick C; Ndayisaba JP; Ulmer H; Pellecchia MT; Barone P; Kim HT; Hooker J; Quinn NP; Cardozo A; Tolosa E; Abele M; Klockgether T; Østergaard K; Dupont E; Schimke N; Eggert KM; Oertel W; Djaldetti R; Poewe W;
    Mov Disord; 2006 Feb; 21(2):179-86. PubMed ID: 16161136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The international cooperative ataxia rating scale in Machado-Joseph disease. Comparison with the unified multiple system atrophy rating scale.
    D'Abreu A; Franca M; Lopes-Cendes I; Cendes F
    Mov Disord; 2007 Oct; 22(13):1976-9. PubMed ID: 17876849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the International Cooperative Ataxia Scale rating in multiple system atrophy.
    Tison F; Yekhlef F; Balestre E; Chrysostome V; Quinn N; Wenning GK; Poewe W
    Mov Disord; 2002 Nov; 17(6):1248-54. PubMed ID: 12465064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of multiple system atrophy in the USA: a prospective cohort study.
    Low PA; Reich SG; Jankovic J; Shults CW; Stern MB; Novak P; Tanner CM; Gilman S; Marshall FJ; Wooten F; Racette B; Chelimsky T; Singer W; Sletten DM; Sandroni P; Mandrekar J
    Lancet Neurol; 2015 Jul; 14(7):710-9. PubMed ID: 26025783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal temporal discrimination threshold in patients with multiple system atrophy.
    Lyoo CH; Lee SY; Song TJ; Lee MS
    Mov Disord; 2007 Mar; 22(4):556-9. PubMed ID: 17260339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential outcome measures and trial design issues for multiple system atrophy.
    May S; Gilman S; Sowell BB; Thomas RG; Stern MB; Colcher A; Tanner CM; Huang N; Novak P; Reich SG; Jankovic J; Ondo WG; Low PA; Sandroni P; Lipp A; Marshall FJ; Wooten F; Shults CW;
    Mov Disord; 2007 Dec; 22(16):2371-7. PubMed ID: 17914727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.
    Martínez-Martín P; Gil-Nagel A; Gracia LM; Gómez JB; Martínez-Sarriés J; Bermejo F
    Mov Disord; 1994 Jan; 9(1):76-83. PubMed ID: 8139608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time.
    Damon-Perrière N; Foubert-Samier A; De Cock VC; Gerdelat-Mas A; Debs R; Pavy-Le Traon A; Senard JM; Rascol O; Tison F; Meissner WG
    Parkinsonism Relat Disord; 2012 Jun; 18(5):612-5. PubMed ID: 22236582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The European Multiple System Atrophy-Study Group (EMSA-SG).
    Geser F; Seppi K; Stampfer-Kountchev M; Köllensperger M; Diem A; Ndayisaba JP; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Abele M; Dodel R; Klockgether T; Ghorayeb I; Yekhlef F; Tison F; Daniels C; Kopper F; Deuschl G; Coelho M; Ferreira J; Rosa MM; Sampaio C; Bozi M; Schrag A; Hooker J; Kim H; Scaravilli T; Mathias CJ; Fowler C; Wood N; Quinn N; Widner H; Nilsson CF; Lindvall O; Schimke N; Eggert KM; Oertel W; del Sorbo F; Carella F; Albanese A; Pellecchia MT; Barone P; Djaldetti R; Meco G; Colosimo C; Gonzalez-Mandly A; Berciano J; Gurevich T; Giladi N; Galitzky M; Ory F; Rascol O; Kamm C; Buerk K; Maass S; Gasser T; Poewe W; Wenning GK;
    J Neural Transm (Vienna); 2005 Dec; 112(12):1677-86. PubMed ID: 16049636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grading of neuropathology in multiple system atrophy: proposal for a novel scale.
    Jellinger KA; Seppi K; Wenning GK
    Mov Disord; 2005 Aug; 20 Suppl 12():S29-36. PubMed ID: 16092088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease.
    Ramaker C; Marinus J; Stiggelbout AM; Van Hilten BJ
    Mov Disord; 2002 Sep; 17(5):867-76. PubMed ID: 12360535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of quality of life in multiple system atrophy and Parkinson's disease].
    Torny F; Lacoste M; Videaud H; Chouly M; Parveau MC; Couratier P
    Rev Neurol (Paris); 2009 Nov; 165(11):911-5. PubMed ID: 19324385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Different Symptom Assessment Scales for Multiple System Atrophy.
    Matsushima M; Yabe I; Oba K; Sakushima K; Mito Y; Takei A; Houzen H; Tsuzaka K; Yoshida K; Maruo Y; Sasaki H
    Cerebellum; 2016 Apr; 15(2):190-200. PubMed ID: 26093615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Unified Dyskinesia Rating Scale: presentation and clinimetric profile.
    Goetz CG; Nutt JG; Stebbins GT
    Mov Disord; 2008 Dec; 23(16):2398-403. PubMed ID: 19025759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.
    Siderowf A; McDermott M; Kieburtz K; Blindauer K; Plumb S; Shoulson I;
    Mov Disord; 2002 Jul; 17(4):758-63. PubMed ID: 12210871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials.
    Rabey JM; Bass H; Bonuccelli U; Brooks D; Klotz P; Korczyn AD; Kraus P; Martinez-Martin P; Morrish P; Van Sauten W; Van Hilten B
    Clin Neuropharmacol; 1997 Aug; 20(4):322-37. PubMed ID: 9260730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
    Köllensperger M; Geser F; Ndayisaba JP; Boesch S; Seppi K; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Abele M; Klockgether T; Yekhlef F; Tison F; Daniels C; Deuschl G; Coelho M; Sampaio C; Bozi M; Quinn N; Schrag A; Mathias CJ; Fowler C; Nilsson CF; Widner H; Schimke N; Oertel W; Del Sorbo F; Albanese A; Pellecchia MT; Barone P; Djaldetti R; Colosimo C; Meco G; Gonzalez-Mandly A; Berciano J; Gurevich T; Giladi N; Galitzky M; Rascol O; Kamm C; Gasser T; Siebert U; Poewe W; Wenning GK;
    Mov Disord; 2010 Nov; 25(15):2604-12. PubMed ID: 20922810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unified Parkinson's disease rating scale motor examination: are ratings of nurses, residents in neurology, and movement disorders specialists interchangeable?
    Post B; Merkus MP; de Bie RM; de Haan RJ; Speelman JD
    Mov Disord; 2005 Dec; 20(12):1577-84. PubMed ID: 16116612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.